NATURE’S SUNSHINE PRODUCTS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.69 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2018-03-16
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-09-30 was $0.22, a 120.00% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-06-30 was $0.14, a 7.69% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-03-31 was $0.11, a 52.17% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2015-12-31 was $0.19, a 280.00% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for fiscal 2017 was -$0.69, a 727.27% decline from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for fiscal 2016 was $0.11, a 83.33% decline from fiscal 2015.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for fiscal 2015 was $0.66, a 41.07% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, per diluted share for fiscal 2014 was $1.12, a 3.70% increase from fiscal 2013.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | -$0.69 10-K · filed 2018-03-16 | |||||
| 2016-12-31 | $0.11 10-K · filed 2018-03-16 | |||||
| 2016-09-30 | $0.22 10-Q · filed 2016-11-09 | $0.46 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | $0.14 10-Q · filed 2016-08-09 | $0.24 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | $0.11 10-Q · filed 2016-05-10 | |||||
| 2015-12-31 | $0.19 10-K · filed 2017-03-14 | $0.66 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $0.10 10-K · filed 2017-03-14 | $0.08 10-Q · filed 2015-11-06 | $0.43 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $0.13 10-K · filed 2017-03-14 | $0.12 10-Q · filed 2015-08-10 | $0.34 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $0.23 10-K · filed 2017-03-14 | $0.22 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | $0.05 10-K · filed 2016-03-14 | $1.12 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $0.29 10-K · filed 2016-03-14 | $1.11 10-Q · filed 2015-11-06 | ||||
| 2014-06-30 | $0.22 10-K · filed 2016-03-14 | $0.84 10-Q · filed 2015-08-10 | ||||
| 2014-03-31 | $0.61 10-K · filed 2016-03-14 | |||||
| 2013-12-31 | $0.11 10-K · filed 2015-03-13 | $1.08 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $0.28 10-K · filed 2015-03-13 | |||||
| 2013-06-30 | $0.38 10-K · filed 2015-03-13 | |||||
| 2013-03-31 | $0.31 10-K · filed 2015-03-13 | |||||
| 2012-12-31 | $1.56 10-K · filed 2015-03-13 | $1.59 10-K · filed 2013-03-07 | ||||
| 2011-12-31 | $1.12 10-K · filed 2013-03-07 | |||||
| 2011-09-30 | -$0.14 10-Q · filed 2011-11-08 | $0.64 10-Q · filed 2011-11-08 | ||||
| 2011-06-30 | $0.36 10-Q · filed 2011-08-05 | $0.78 10-Q · filed 2011-08-05 | ||||
| 2010-12-31 | $0.54 10-K · filed 2013-03-07 | |||||
| 2010-09-30 | $0.17 10-Q · filed 2011-11-08 | $0.57 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $0.09 10-Q · filed 2011-08-05 | $0.40 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $0.42 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |